DalsnaFinance › Analyst accuracy › Baird › HUM target
Humana options activity surges after Medicare Advantage star ratings upgrade
Analyst moves: Baird upgraded the stock to Outperform and raised its target to $596 from $390.
A fact about what Baird published, as reported by Investing.com, not a recommendation from Dalsna Finance; Baird is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.